HEADER TRANSFERASE 08-MAY-19 6RNA TITLE RIP2 KINASE CATALYTIC DOMAIN COMPLEX WITH 2({4[(1,3BENZOTHIAZOL5YL) TITLE 2 AMINO]6(2METHYLPROPANE2SULFONYL)QUINAZOLIN7YL}OXY)ETHAN1OL COMPND MOL_ID: 1; COMPND 2 MOLECULE: RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CARD-CONTAINING INTERLEUKIN-1 BETA-CONVERTING ENZYME- COMPND 5 ASSOCIATED KINASE,CARD-CONTAINING IL-1 BETA ICE-KINASE,RIP-LIKE- COMPND 6 INTERACTING CLARP KINASE,RECEPTOR-INTERACTING PROTEIN 2,RIP-2, COMPND 7 TYROSINE-PROTEIN KINASE RIPK2; COMPND 8 EC: 2.7.11.1,2.7.10.2; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RIPK2, CARDIAK, RICK, RIP2, UNQ277/PRO314/PRO34092; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE, STRUCTURE BASED DRUG DISCOVERY, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.A.CONVERY,P.A.HAILE REVDAT 3 24-JAN-24 6RNA 1 REMARK REVDAT 2 07-AUG-19 6RNA 1 JRNL REVDAT 1 17-JUL-19 6RNA 0 JRNL AUTH P.A.HAILE,L.N.CASILLAS,B.J.VOTTA,G.Z.WANG,A.K.CHARNLEY, JRNL AUTH 2 X.DONG,M.J.BURY,J.J.ROMANO,J.F.MEHLMANN,B.W.KING,K.F.ERHARD, JRNL AUTH 3 C.R.HANNING,D.B.LIPSHUTZ,B.M.DESAI,C.A.CAPRIOTTI, JRNL AUTH 4 M.C.SCHAEFFER,S.B.BERGER,M.K.MAHAJAN,M.A.REILLY,R.NAGILLA, JRNL AUTH 5 E.J.RIVERA,H.H.SUN,J.K.KENNA,A.M.BEAL,M.T.OUELLETTE,M.KELLY, JRNL AUTH 6 G.STEMP,M.A.CONVERY,A.VOSSENKAMPER,T.T.MACDONALD,P.J.GOUGH, JRNL AUTH 7 J.BERTIN,R.W.MARQUIS JRNL TITL DISCOVERY OF A FIRST-IN-CLASS RECEPTOR INTERACTING PROTEIN 2 JRNL TITL 2 (RIP2) KINASE SPECIFIC CLINICAL CANDIDATE, JRNL TITL 3 2-((4-(BENZO[D]THIAZOL-5-YLAMINO)-6-(TERT-BUTYLSULFONYL) JRNL TITL 4 QUINAZOLIN-7-YL)OXY)ETHYL DIHYDROGEN PHOSPHATE, FOR THE JRNL TITL 5 TREATMENT OF INFLAMMATORY DISEASES. JRNL REF J.MED.CHEM. V. 62 6482 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 31265286 JRNL DOI 10.1021/ACS.JMEDCHEM.9B00575 REMARK 2 REMARK 2 RESOLUTION. 2.62 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.62 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.11 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 32898 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.162 REMARK 3 R VALUE (WORKING SET) : 0.161 REMARK 3 FREE R VALUE : 0.190 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 1670 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.62 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.64 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.34 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 658 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2071 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 626 REMARK 3 BIN R VALUE (WORKING SET) : 0.2063 REMARK 3 BIN FREE R VALUE : 0.2222 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.86 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4529 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 237 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 65.39 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 67.92 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.14190 REMARK 3 B22 (A**2) : -5.14190 REMARK 3 B33 (A**2) : 10.28390 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.270 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.256 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.190 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.251 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.190 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4715 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6419 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1594 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 786 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4715 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 609 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5278 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.05 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.05 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.82 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -48.5237 40.3737 4.6915 REMARK 3 T TENSOR REMARK 3 T11: -0.2061 T22: -0.0489 REMARK 3 T33: -0.1200 T12: -0.0373 REMARK 3 T13: -0.0090 T23: -0.0654 REMARK 3 L TENSOR REMARK 3 L11: 1.4092 L22: 2.3112 REMARK 3 L33: 2.8098 L12: 1.0425 REMARK 3 L13: -0.8425 L23: 0.6950 REMARK 3 S TENSOR REMARK 3 S11: 0.1080 S12: -0.1596 S13: 0.0385 REMARK 3 S21: 0.1254 S22: 0.1098 S23: -0.3910 REMARK 3 S31: -0.1090 S32: 0.5740 S33: -0.2178 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -54.2437 14.6109 -13.3240 REMARK 3 T TENSOR REMARK 3 T11: 0.0414 T22: -0.2552 REMARK 3 T33: -0.2099 T12: -0.0014 REMARK 3 T13: 0.0949 T23: -0.0495 REMARK 3 L TENSOR REMARK 3 L11: 0.8780 L22: 4.1213 REMARK 3 L33: 2.3929 L12: 0.1795 REMARK 3 L13: -0.5580 L23: 0.4298 REMARK 3 S TENSOR REMARK 3 S11: -0.2657 S12: 0.0945 S13: -0.0840 REMARK 3 S21: -0.6210 S22: 0.1906 S23: -0.3786 REMARK 3 S31: 0.7290 S32: 0.0412 S33: 0.0752 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6RNA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-MAY-19. REMARK 100 THE DEPOSITION ID IS D_1292102232. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-JAN-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32951 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.620 REMARK 200 RESOLUTION RANGE LOW (A) : 78.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.62 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.37800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: 5AR4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM MES PH7, 12% PEG 400, 250MM REMARK 280 CACL2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 71.44667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 35.72333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 35.72333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 71.44667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3690 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24530 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MET A 1 REMARK 465 ASN A 2 REMARK 465 GLY A 3 REMARK 465 GLU A 4 REMARK 465 ALA A 28 REMARK 465 LEU A 49 REMARK 465 HIS A 50 REMARK 465 ILE A 51 REMARK 465 HIS A 52 REMARK 465 THR A 53 REMARK 465 PRO A 54 REMARK 465 MET A 173 REMARK 465 SER A 174 REMARK 465 LEU A 175 REMARK 465 SER A 176 REMARK 465 GLN A 177 REMARK 465 SER A 178 REMARK 465 ARG A 179 REMARK 465 SER A 180 REMARK 465 SER A 181 REMARK 465 LYS A 182 REMARK 465 SER A 183 REMARK 465 ALA A 184 REMARK 465 PRO A 185 REMARK 465 GLU A 186 REMARK 465 GLU A 199 REMARK 465 PRO A 200 REMARK 465 GLY A 201 REMARK 465 GLN A 202 REMARK 465 LYS A 203 REMARK 465 SER A 204 REMARK 465 ARG A 205 REMARK 465 ALA A 206 REMARK 465 GLY B 0 REMARK 465 MET B 1 REMARK 465 ASN B 2 REMARK 465 GLY B 3 REMARK 465 GLY B 27 REMARK 465 ALA B 28 REMARK 465 SER B 29 REMARK 465 LEU B 49 REMARK 465 HIS B 50 REMARK 465 ILE B 51 REMARK 465 HIS B 52 REMARK 465 THR B 53 REMARK 465 PRO B 54 REMARK 465 LEU B 55 REMARK 465 MET B 173 REMARK 465 SER B 174 REMARK 465 LEU B 175 REMARK 465 SER B 176 REMARK 465 GLN B 177 REMARK 465 SER B 178 REMARK 465 ARG B 179 REMARK 465 SER B 180 REMARK 465 SER B 181 REMARK 465 LYS B 182 REMARK 465 SER B 183 REMARK 465 ALA B 184 REMARK 465 PRO B 185 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 55 CG CD1 CD2 REMARK 470 LEU A 56 CG CD1 CD2 REMARK 470 ASP A 57 CG OD1 OD2 REMARK 470 GLU A 59 CG CD OE1 OE2 REMARK 470 LYS A 61 CG CD CE NZ REMARK 470 GLU B 4 CG CD OE1 OE2 REMARK 470 ARG B 26 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 56 CG CD1 CD2 REMARK 470 ASP B 57 CG OD1 OD2 REMARK 470 GLU B 59 CG CD OE1 OE2 REMARK 470 GLU B 186 CG CD OE1 OE2 REMARK 470 GLN B 202 CG CD OE1 NE2 REMARK 470 LYS B 203 CG CD CE NZ REMARK 470 ARG B 205 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 146 47.16 -157.66 REMARK 500 ASP A 164 86.33 59.47 REMARK 500 LEU B 24 -68.57 -107.36 REMARK 500 ASP B 146 42.81 -154.01 REMARK 500 ASP B 164 86.20 60.07 REMARK 500 SER B 207 124.93 -31.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KA2 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KA2 B 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6RN8 RELATED DB: PDB DBREF 6RNA A 1 310 UNP O43353 RIPK2_HUMAN 1 310 DBREF 6RNA B 1 310 UNP O43353 RIPK2_HUMAN 1 310 SEQADV 6RNA GLY A 0 UNP O43353 EXPRESSION TAG SEQADV 6RNA GLY B 0 UNP O43353 EXPRESSION TAG SEQRES 1 A 311 GLY MET ASN GLY GLU ALA ILE CYS SER ALA LEU PRO THR SEQRES 2 A 311 ILE PRO TYR HIS LYS LEU ALA ASP LEU ARG TYR LEU SER SEQRES 3 A 311 ARG GLY ALA SER GLY THR VAL SER SER ALA ARG HIS ALA SEQRES 4 A 311 ASP TRP ARG VAL GLN VAL ALA VAL LYS HIS LEU HIS ILE SEQRES 5 A 311 HIS THR PRO LEU LEU ASP SER GLU ARG LYS ASP VAL LEU SEQRES 6 A 311 ARG GLU ALA GLU ILE LEU HIS LYS ALA ARG PHE SER TYR SEQRES 7 A 311 ILE LEU PRO ILE LEU GLY ILE CYS ASN GLU PRO GLU PHE SEQRES 8 A 311 LEU GLY ILE VAL THR GLU TYR MET PRO ASN GLY SER LEU SEQRES 9 A 311 ASN GLU LEU LEU HIS ARG LYS THR GLU TYR PRO ASP VAL SEQRES 10 A 311 ALA TRP PRO LEU ARG PHE ARG ILE LEU HIS GLU ILE ALA SEQRES 11 A 311 LEU GLY VAL ASN TYR LEU HIS ASN MET THR PRO PRO LEU SEQRES 12 A 311 LEU HIS HIS ASP LEU LYS THR GLN ASN ILE LEU LEU ASP SEQRES 13 A 311 ASN GLU PHE HIS VAL LYS ILE ALA ASP PHE GLY LEU SER SEQRES 14 A 311 LYS TRP ARG MET MET SER LEU SER GLN SER ARG SER SER SEQRES 15 A 311 LYS SER ALA PRO GLU GLY GLY THR ILE ILE TYR MET PRO SEQRES 16 A 311 PRO GLU ASN TYR GLU PRO GLY GLN LYS SER ARG ALA SER SEQRES 17 A 311 ILE LYS HIS ASP ILE TYR SER TYR ALA VAL ILE THR TRP SEQRES 18 A 311 GLU VAL LEU SER ARG LYS GLN PRO PHE GLU ASP VAL THR SEQRES 19 A 311 ASN PRO LEU GLN ILE MET TYR SER VAL SER GLN GLY HIS SEQRES 20 A 311 ARG PRO VAL ILE ASN GLU GLU SER LEU PRO TYR ASP ILE SEQRES 21 A 311 PRO HIS ARG ALA ARG MET ILE SER LEU ILE GLU SER GLY SEQRES 22 A 311 TRP ALA GLN ASN PRO ASP GLU ARG PRO SER PHE LEU LYS SEQRES 23 A 311 CYS LEU ILE GLU LEU GLU PRO VAL LEU ARG THR PHE GLU SEQRES 24 A 311 GLU ILE THR PHE LEU GLU ALA VAL ILE GLN LEU LYS SEQRES 1 B 311 GLY MET ASN GLY GLU ALA ILE CYS SER ALA LEU PRO THR SEQRES 2 B 311 ILE PRO TYR HIS LYS LEU ALA ASP LEU ARG TYR LEU SER SEQRES 3 B 311 ARG GLY ALA SER GLY THR VAL SER SER ALA ARG HIS ALA SEQRES 4 B 311 ASP TRP ARG VAL GLN VAL ALA VAL LYS HIS LEU HIS ILE SEQRES 5 B 311 HIS THR PRO LEU LEU ASP SER GLU ARG LYS ASP VAL LEU SEQRES 6 B 311 ARG GLU ALA GLU ILE LEU HIS LYS ALA ARG PHE SER TYR SEQRES 7 B 311 ILE LEU PRO ILE LEU GLY ILE CYS ASN GLU PRO GLU PHE SEQRES 8 B 311 LEU GLY ILE VAL THR GLU TYR MET PRO ASN GLY SER LEU SEQRES 9 B 311 ASN GLU LEU LEU HIS ARG LYS THR GLU TYR PRO ASP VAL SEQRES 10 B 311 ALA TRP PRO LEU ARG PHE ARG ILE LEU HIS GLU ILE ALA SEQRES 11 B 311 LEU GLY VAL ASN TYR LEU HIS ASN MET THR PRO PRO LEU SEQRES 12 B 311 LEU HIS HIS ASP LEU LYS THR GLN ASN ILE LEU LEU ASP SEQRES 13 B 311 ASN GLU PHE HIS VAL LYS ILE ALA ASP PHE GLY LEU SER SEQRES 14 B 311 LYS TRP ARG MET MET SER LEU SER GLN SER ARG SER SER SEQRES 15 B 311 LYS SER ALA PRO GLU GLY GLY THR ILE ILE TYR MET PRO SEQRES 16 B 311 PRO GLU ASN TYR GLU PRO GLY GLN LYS SER ARG ALA SER SEQRES 17 B 311 ILE LYS HIS ASP ILE TYR SER TYR ALA VAL ILE THR TRP SEQRES 18 B 311 GLU VAL LEU SER ARG LYS GLN PRO PHE GLU ASP VAL THR SEQRES 19 B 311 ASN PRO LEU GLN ILE MET TYR SER VAL SER GLN GLY HIS SEQRES 20 B 311 ARG PRO VAL ILE ASN GLU GLU SER LEU PRO TYR ASP ILE SEQRES 21 B 311 PRO HIS ARG ALA ARG MET ILE SER LEU ILE GLU SER GLY SEQRES 22 B 311 TRP ALA GLN ASN PRO ASP GLU ARG PRO SER PHE LEU LYS SEQRES 23 B 311 CYS LEU ILE GLU LEU GLU PRO VAL LEU ARG THR PHE GLU SEQRES 24 B 311 GLU ILE THR PHE LEU GLU ALA VAL ILE GLN LEU LYS HET KA2 A 401 31 HET KA2 B 401 31 HETNAM KA2 2-[4-(1,3-BENZOTHIAZOL-5-YLAMINO)-6-~{TERT}- HETNAM 2 KA2 BUTYLSULFONYL-QUINAZOLIN-7-YL]OXYETHANOL FORMUL 3 KA2 2(C21 H22 N4 O4 S2) FORMUL 5 HOH *237(H2 O) HELIX 1 AA1 PRO A 14 HIS A 16 5 3 HELIX 2 AA2 ASP A 57 ALA A 73 1 17 HELIX 3 AA3 SER A 102 ARG A 109 1 8 HELIX 4 AA4 ALA A 117 MET A 138 1 22 HELIX 5 AA5 LYS A 148 GLN A 150 5 3 HELIX 6 AA6 PRO A 194 TYR A 198 5 5 HELIX 7 AA7 LYS A 209 ARG A 225 1 17 HELIX 8 AA8 ASN A 234 GLN A 244 1 11 HELIX 9 AA9 HIS A 261 TRP A 273 1 13 HELIX 10 AB1 ASN A 276 ARG A 280 5 5 HELIX 11 AB2 SER A 282 ARG A 295 1 14 HELIX 12 AB3 GLU A 298 LYS A 310 1 13 HELIX 13 AB4 PRO B 14 HIS B 16 5 3 HELIX 14 AB5 ASP B 57 ALA B 73 1 17 HELIX 15 AB6 SER B 102 ARG B 109 1 8 HELIX 16 AB7 ALA B 117 MET B 138 1 22 HELIX 17 AB8 LYS B 148 GLN B 150 5 3 HELIX 18 AB9 PRO B 194 TYR B 198 5 5 HELIX 19 AC1 GLY B 201 SER B 207 1 7 HELIX 20 AC2 LYS B 209 ARG B 225 1 17 HELIX 21 AC3 ASN B 234 GLN B 244 1 11 HELIX 22 AC4 HIS B 261 TRP B 273 1 13 HELIX 23 AC5 ASN B 276 ARG B 280 5 5 HELIX 24 AC6 SER B 282 ARG B 295 1 14 HELIX 25 AC7 THR B 296 GLU B 298 5 3 HELIX 26 AC8 GLU B 299 LYS B 310 1 12 SHEET 1 AA1 2 CYS A 7 ALA A 9 0 SHEET 2 AA1 2 CYS B 7 ALA B 9 -1 O SER B 8 N SER A 8 SHEET 1 AA2 5 LEU A 18 ARG A 26 0 SHEET 2 AA2 5 THR A 31 HIS A 37 -1 O ARG A 36 N ALA A 19 SHEET 3 AA2 5 GLN A 43 HIS A 48 -1 O VAL A 44 N ALA A 35 SHEET 4 AA2 5 LEU A 91 GLU A 96 -1 O THR A 95 N ALA A 45 SHEET 5 AA2 5 ILE A 81 ASN A 86 -1 N CYS A 85 O GLY A 92 SHEET 1 AA3 2 LEU A 142 LEU A 143 0 SHEET 2 AA3 2 LYS A 169 TRP A 170 -1 O LYS A 169 N LEU A 143 SHEET 1 AA4 2 ILE A 152 LEU A 154 0 SHEET 2 AA4 2 VAL A 160 ILE A 162 -1 O LYS A 161 N LEU A 153 SHEET 1 AA5 5 LEU B 18 SER B 25 0 SHEET 2 AA5 5 THR B 31 HIS B 37 -1 O ARG B 36 N ALA B 19 SHEET 3 AA5 5 GLN B 43 HIS B 48 -1 O VAL B 44 N ALA B 35 SHEET 4 AA5 5 LEU B 91 GLU B 96 -1 O ILE B 93 N LYS B 47 SHEET 5 AA5 5 ILE B 81 ASN B 86 -1 N CYS B 85 O GLY B 92 SHEET 1 AA6 2 LEU B 142 LEU B 143 0 SHEET 2 AA6 2 LYS B 169 TRP B 170 -1 O LYS B 169 N LEU B 143 SHEET 1 AA7 2 ILE B 152 LEU B 154 0 SHEET 2 AA7 2 VAL B 160 ILE B 162 -1 O LYS B 161 N LEU B 153 CISPEP 1 THR A 139 PRO A 140 0 -0.82 CISPEP 2 THR B 139 PRO B 140 0 -1.47 SITE 1 AC1 18 LEU A 24 SER A 25 VAL A 32 ALA A 45 SITE 2 AC1 18 LYS A 47 GLU A 66 LEU A 70 LEU A 79 SITE 3 AC1 18 THR A 95 GLU A 96 TYR A 97 MET A 98 SITE 4 AC1 18 PRO A 99 GLY A 101 GLU A 105 LEU A 153 SITE 5 AC1 18 ALA A 163 ASP A 164 SITE 1 AC2 16 LEU B 24 SER B 25 ALA B 45 LYS B 47 SITE 2 AC2 16 GLU B 66 LEU B 70 LEU B 79 THR B 95 SITE 3 AC2 16 GLU B 96 MET B 98 GLY B 101 GLU B 105 SITE 4 AC2 16 LEU B 153 ALA B 163 ASP B 164 HOH B 531 CRYST1 132.420 132.420 107.170 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007552 0.004360 0.000000 0.00000 SCALE2 0.000000 0.008720 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009331 0.00000